Medical researchers have identified a human blood cell type that can only differentiate into monocytes, and is equivalent to mouse cells identified in earlier work. The cells can be recognized by their expression of particular membranous signaling proteins, and were shown to be part of a sequential differentiation process into monocytes. This alternative road map for immune cell development may lead to new targeted therapeutic applications.